万春药业(BYSI)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

BYSI 万春药业

交易中 05-16 09:32:03 EDT

1.65

-0.05

-2.94%

最高1.65	最低1.65	成交量637.00
今开1.65	昨收1.70	日振幅0.00%
总市值6,652万	流通市值4,918万	总股本4,032万
成交额1,051	换手率0.00%	流通股本2,980万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

{"stockData":{"symbol":"BYSI","market":"US","secType":"STK","nameCN":"万春药业","latestPrice":1.65,"timestamp":1747402205852,"preClose":1.7,"halted":0,"volume":637,"delay":0,"floatShares":29804037,"shares":40316320,"eps":-0.085257,"marketStatus":"交易中","change":-0.05,"latestTime":"05-16 09:32:03 EDT","open":1.65,"high":1.65,"low":1.65,"amount":1051.0999408,"amplitude":0,"askPrice":1.77,"askSize":72,"bidPrice":1.62,"bidSize":223,"shortable":3,"etf":0,"ttmEps":-0.085257,"tradingStatus":2,"nextMarketStatus":{"tag":"盘后交易","tradingStatus":3,"beginTime":1747425600000},"marketStatusCode":2,"adr":0,"adrRate":0,"listingDate":1489035600000,"exchange":"NASDAQ","adjPreClose":1.7,"postHourTrading":{"tag":"盘后","latestPrice":1.68,"preClose":1.68,"latestTime":"17:36 EDT","volume":3,"amount":5.2,"timestamp":1747345005570},"volumeRatio":6.578174,"impliedVol":0.249,"impliedVolPercentile":0.404},"requestUrl":"/m/hq/s/BYSI","defaultTab":"news","newsList":[{"id":"2535836619","title":"万春医药5月14日成交额为7186.00美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2535836619","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2535836619?lang=zh_cn&edition=full","pubTime":"2025-05-15 09:21","pubTimestamp":1747272080,"startTime":"0","endTime":"0","summary":"美东时间2025年5月14日，万春医药成交额为7186.00美元，成交额较昨日减少73.30%，当日成交量为4237.00股。万春医药于2025年5月14日跌2.07%，报1.68美元，该股过去5个交易日跌0.91%，年初至今涨3.34%，过去60日跌0.91%。|近5个交易日成交情况||||#|日期|成交额（美元）|成交额较昨日变化|成交量（股）|#|2025-05-14|7186.00|-73.30%|4237.00|#|2025-05-13|2.69万|23.86%|1.54万|#|2025-05-12|2.17万|-44.29%|1.33万|#|2025-05-09|3.90万|17.12%|2.34万|#|2025-05-08|3.33万|-84.13%|1.88万|BeyondSpring Inc 从事临床阶段的生物制药活动，重点是开发癌症疗法。该公司还专注于包括免疫肿瘤药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250515092121a47ed84b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250515092121a47ed84b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","BYSI"],"gpt_icon":0},{"id":"2535648758","title":"万春医药5月12日成交额为2.17万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2535648758","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2535648758?lang=zh_cn&edition=full","pubTime":"2025-05-13 09:20","pubTimestamp":1747099238,"startTime":"0","endTime":"0","summary":"美东时间2025年5月12日，万春医药成交额为2.17万美元，成交额较昨日减少44.29%，当日成交量为1.33万股。万春医药于2025年5月12日跌1.79%，报1.65美元，该股过去5个交易日跌1.2%，年初至今涨1.23%，过去60日跌2.94%。|近5个交易日成交情况||||#|日期|成交额（美元）|成交额较昨日变化|成交量（股）|#|2025-05-12|2.17万|-44.29%|1.33万|#|2025-05-09|3.90万|17.12%|2.34万|#|2025-05-08|3.33万|-84.13%|1.88万|#|2025-05-07|20.98万|-22.75%|11.05万|#|2025-05-06|27.16万|8224.55%|13.62万|BeyondSpring Inc 从事临床阶段的生物制药活动，重点是开发癌症疗法。该公司还专注于包括免疫肿瘤药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250513092049a6dcd881&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250513092049a6dcd881&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","BYSI"],"gpt_icon":0},{"id":"2533135718","title":"万春医药盘中异动 急速拉升7.65%报1.83美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2533135718","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2533135718?lang=zh_cn&edition=full","pubTime":"2025-05-08 21:35","pubTimestamp":1746711317,"startTime":"0","endTime":"0","summary":"北京时间2025年05月08日21时35分，万春医药股票出现波动，股价急速上涨7.65%。截至发稿，该股报1.83美元/股，成交量7163股，换手率0.02%，振幅0.00%。万春医药股票所在的生物技术行业中，整体跌幅为2.62%。万春医药公司简介：BeyondSpring Inc 从事临床阶段的生物制药活动，重点是开发癌症疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250508213517a476d02f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250508213517a476d02f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","BYSI"],"gpt_icon":0},{"id":"2533913168","title":"万春医药5月7日成交额为20.98万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2533913168","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2533913168?lang=zh_cn&edition=full","pubTime":"2025-05-08 09:19","pubTimestamp":1746667172,"startTime":"0","endTime":"0","summary":"美东时间2025年5月7日，万春医药成交额为20.98万美元，成交额较昨日减少22.75%，当日成交量为11.05万股。万春医药于2025年5月7日跌20.19%，报1.7美元，该股过去5个交易日跌2.3%，年初至今涨4.29%，过去60日跌1.73%。|近5个交易日成交情况||||#|日期|成交额（美元）|成交额较昨日变化|成交量（股）|#|2025-05-07|20.98万|-22.75%|11.05万|#|2025-05-06|27.16万|8224.55%|13.62万|#|2025-05-05|3263.00|-83.25%|1935.00|#|2025-05-02|1.95万|-64.05%|1.12万|#|2025-05-01|5.42万|-48.09%|3.07万|BeyondSpring Inc 从事临床阶段的生物制药活动，重点是开发癌症疗法。该公司还专注于包括免疫肿瘤药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250508091944a6d6f7e3&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250508091944a6d6f7e3&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","BYSI"],"gpt_icon":0},{"id":"2533939126","title":"万春医药盘中异动 股价大跌5.16%","url":"https://stock-news.laohu8.com/highlight/detail?id=2533939126","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2533939126?lang=zh_cn&edition=full","pubTime":"2025-05-07 21:33","pubTimestamp":1746624797,"startTime":"0","endTime":"0","summary":"北京时间2025年05月07日21时33分，万春医药股票出现波动，股价快速下跌5.16%。截至发稿，该股报2.02美元/股，成交量4623股，换手率0.01%，振幅0.00%。机构评级方面，目前暂无机构对该股做出“买入、持有、卖出”建议。万春医药股票所在的生物技术行业中，整体跌幅为0.13%。万春医药公司简介：BeyondSpring Inc 从事临床阶段的生物制药活动，重点是开发癌症疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250507213317a4756ea7&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250507213317a4756ea7&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","BYSI"],"gpt_icon":0},{"id":"2533616686","title":"万春医药盘中异动 急速拉升20.66%报2.02美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2533616686","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2533616686?lang=zh_cn&edition=full","pubTime":"2025-05-07 03:41","pubTimestamp":1746560513,"startTime":"0","endTime":"0","summary":"北京时间2025年05月07日03时41分，万春医药股票出现波动，股价急速拉升20.66%。截至发稿，该股报2.02美元/股，成交量1.4084万股，换手率0.03%，振幅2.69%。万春医药股票所在的生物技术行业中，整体跌幅为5.59%。万春医药公司简介：BeyondSpring Inc 从事临床阶段的生物制药活动，重点是开发癌症疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025050703415397510020&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025050703415397510020&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BYSI","BK4139","KTTA"],"gpt_icon":0},{"id":"2533165225","title":"万春医药上涨2.1%，报1.705美元/股，总市值6873.93万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2533165225","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2533165225?lang=zh_cn&edition=full","pubTime":"2025-05-07 00:24","pubTimestamp":1746548654,"startTime":"0","endTime":"0","summary":"5月7日，万春医药盘中上涨2.1%，截至00:24，报1.705美元/股，成交4461.0美元，总市值6873.93万美元。财务数据显示，截至2024年06月30日，万春医药收入总额100.0万美元，同比增长14.29%；归母净利润-726.2万美元，同比增长42.91%。大事提醒：5月5日，万春医药将披露2024财年年报。资料显示，万春药业公司是一家处于全球临床阶段的生物制药公司,专注于新型癌症疗法,包括晚期肿瘤免疫药物的研发。公司成立于2013年,总部设立在美国。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025050700330694ee3004&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025050700330694ee3004&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","BYSI"],"gpt_icon":0},{"id":"2532934878","title":"万春医药盘中异动 下午盘大幅跳水5.03%","url":"https://stock-news.laohu8.com/highlight/detail?id=2532934878","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2532934878?lang=zh_cn&edition=full","pubTime":"2025-05-03 01:57","pubTimestamp":1746208625,"startTime":"0","endTime":"0","summary":"北京时间2025年05月03日01时57分，万春医药股票出现波动，股价快速下跌5.03%。截至发稿，该股报1.70美元/股，成交量6989股，换手率0.02%，振幅3.91%。机构评级方面，目前暂无机构对该股做出“买入、持有、卖出”建议。万春医药股票所在的生物技术行业中，整体涨幅为0.79%。万春医药公司简介：BeyondSpring Inc 从事临床阶段的生物制药活动，重点是开发癌症疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250503015706a6d14eb1&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250503015706a6d14eb1&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BYSI","BK4139","IBO","BK4007"],"gpt_icon":0},{"id":"2532011340","title":"万春医药盘中异动 股价大跌6.32%报1.63美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2532011340","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2532011340?lang=zh_cn&edition=full","pubTime":"2025-05-01 22:52","pubTimestamp":1746111147,"startTime":"0","endTime":"0","summary":"北京时间2025年05月01日22时52分，万春医药股票出现异动，股价快速跳水6.32%。截至发稿，该股报1.63美元/股，成交量6374股，换手率0.02%，振幅7.47%。机构评级方面，目前暂无机构对该股做出“买入、持有、卖出”建议。万春医药股票所在的生物技术行业中，整体涨幅为0.05%。万春医药公司简介：BeyondSpring Inc 从事临床阶段的生物制药活动，重点是开发癌症疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250501225228a46f0155&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250501225228a46f0155&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BYSI","BK4139"],"gpt_icon":0},{"id":"2532918069","title":"万春医药上涨4.52%，报1.62美元/股，总市值6531.24万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2532918069","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2532918069?lang=zh_cn&edition=full","pubTime":"2025-05-01 01:33","pubTimestamp":1746034413,"startTime":"0","endTime":"0","summary":"5月1日，万春医药盘中上涨4.52%，截至01:33，报1.62美元/股，成交4.13万美元，总市值6531.24万美元。财务数据显示，截至2024年06月30日，万春医药收入总额100.0万美元，同比增长14.29%；归母净利润-726.2万美元，同比增长42.91%。大事提醒：5月5日，万春医药将披露2024财年年报。资料显示，万春药业公司是一家处于全球临床阶段的生物制药公司,专注于新型癌症疗法,包括晚期肿瘤免疫药物的研发。公司成立于2013年,总部设立在美国。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025050101422094e93510&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025050101422094e93510&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BYSI","BK4139"],"gpt_icon":0},{"id":"2531007058","title":"万春医药盘中异动 早盘股价大涨5.81%","url":"https://stock-news.laohu8.com/highlight/detail?id=2531007058","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2531007058?lang=zh_cn&edition=full","pubTime":"2025-04-30 21:32","pubTimestamp":1746019938,"startTime":"0","endTime":"0","summary":"北京时间2025年04月30日21时32分，万春医药股票出现波动，股价大幅上涨5.81%。截至发稿，该股报1.64美元/股，成交量2559股，换手率0.01%，振幅0.00%。机构评级方面，目前暂无机构对该股做出“买入、持有、卖出”建议。万春医药股票所在的生物技术行业中，整体涨幅为0.27%。万春医药公司简介：BeyondSpring Inc 从事临床阶段的生物制药活动，重点是开发癌症疗法。该公司还专注于包括免疫肿瘤药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250430213218a6cee82f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250430213218a6cee82f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","BYSI"],"gpt_icon":0},{"id":"2531674126","title":"万春医药4月29日成交额为2.36万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2531674126","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2531674126?lang=zh_cn&edition=full","pubTime":"2025-04-30 09:19","pubTimestamp":1745975957,"startTime":"0","endTime":"0","summary":"美东时间2025年4月29日，万春医药成交额为2.36万美元，成交额较昨日增加75.87%，当日成交量为1.50万股。万春医药于2025年4月29日跌1.27%，报1.55美元，该股过去5个交易日涨13.97%，年初至今跌4.91%，过去60日跌13.41%。|近5个交易日成交情况||||#|日期|成交额（美元）|成交额较昨日变化|成交量（股）|#|2025-04-29|2.36万|75.87%|1.50万|#|2025-04-28|1.34万|-7.09%|8581.00|#|2025-04-25|1.45万|-65.76%|8992.00|#|2025-04-24|4.22万|12.86%|2.65万|#|2025-04-23|3.74万|715.95%|2.75万|BeyondSpring Inc 从事临床阶段的生物制药活动，重点是开发癌症疗法。该公司还专注于包括免疫肿瘤药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250430091926a46ceb11&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250430091926a46ceb11&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","BYSI"],"gpt_icon":0},{"id":"2531213614","title":"万春医药4月28日成交额为1.34万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2531213614","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2531213614?lang=zh_cn&edition=full","pubTime":"2025-04-29 09:19","pubTimestamp":1745889545,"startTime":"0","endTime":"0","summary":"美东时间2025年4月28日，万春医药成交额为1.34万美元，成交额较昨日减少7.09%，当日成交量为8581.00股。万春医药于2025年4月28日跌1.88%，报1.57美元，该股过去5个交易日涨17.16%，年初至今跌3.68%，过去60日跌11.3%。|近5个交易日成交情况||||#|日期|成交额（美元）|成交额较昨日变化|成交量（股）|#|2025-04-28|1.34万|-7.09%|8581.00|#|2025-04-25|1.45万|-65.76%|8992.00|#|2025-04-24|4.22万|12.86%|2.65万|#|2025-04-23|3.74万|715.95%|2.75万|#|2025-04-22|4583.00|-12.37%|3395.00|BeyondSpring Inc 从事临床阶段的生物制药活动，重点是开发癌症疗法。该公司还专注于包括免疫肿瘤药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250429091917a46b3c62&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250429091917a46b3c62&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","BYSI"],"gpt_icon":0},{"id":"2530388522","title":"万春医药盘中异动 大幅下跌6.25%","url":"https://stock-news.laohu8.com/highlight/detail?id=2530388522","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2530388522?lang=zh_cn&edition=full","pubTime":"2025-04-28 22:27","pubTimestamp":1745850451,"startTime":"0","endTime":"0","summary":"北京时间2025年04月28日22时27分，万春医药股票出现异动，股价大幅下跌6.25%。截至发稿，该股报1.50美元/股，成交量187股，换手率0.00%，振幅0.00%。万春医药股票所在的生物技术行业中，整体涨幅为1.24%。万春医药公司简介：BeyondSpring Inc 从事临床阶段的生物制药活动，重点是开发癌症疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025042822273197489ee9&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025042822273197489ee9&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","BYSI"],"gpt_icon":0},{"id":"2530930113","title":"万春医药4月25日成交额为1.45万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2530930113","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2530930113?lang=zh_cn&edition=full","pubTime":"2025-04-26 09:18","pubTimestamp":1745630330,"startTime":"0","endTime":"0","summary":"美东时间2025年4月25日，万春医药成交额为1.45万美元，成交额较昨日减少65.76%，当日成交量为8992.00股。万春医药于2025年4月25日跌2.48%，报1.6美元，该股过去5个交易日涨22.14%，年初至今跌1.84%，过去60日跌7.51%。|近5个交易日成交情况||||#|日期|成交额（美元）|成交额较昨日变化|成交量（股）|#|2025-04-25|1.45万|-65.76%|8992.00|#|2025-04-24|4.22万|12.86%|2.65万|#|2025-04-23|3.74万|715.95%|2.75万|#|2025-04-22|4583.00|-12.37%|3395.00|#|2025-04-21|5230.00|-69.45%|3828.00|BeyondSpring Inc 从事临床阶段的生物制药活动，重点是开发癌症疗法。该公司还专注于包括免疫肿瘤药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250426091901a46784d3&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250426091901a46784d3&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","BYSI"],"gpt_icon":0},{"id":"2530914025","title":"万春医药4月24日成交额为4.22万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2530914025","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2530914025?lang=zh_cn&edition=full","pubTime":"2025-04-25 09:18","pubTimestamp":1745543915,"startTime":"0","endTime":"0","summary":"美东时间2025年4月24日，万春医药成交额为4.22万美元，成交额较昨日增加12.86%，当日成交量为2.65万股。万春医药于2025年4月24日涨9.38%，报1.64美元，该股过去5个交易日涨30.21%，年初至今涨0.66%，过去60日跌8.34%。|近5个交易日成交情况||||#|日期|成交额（美元）|成交额较昨日变化|成交量（股）|#|2025-04-24|4.22万|12.86%|2.65万|#|2025-04-23|3.74万|715.95%|2.75万|#|2025-04-22|4583.00|-12.37%|3395.00|#|2025-04-21|5230.00|-69.45%|3828.00|#|2025-04-17|1.71万|-16.84%|1.33万|BeyondSpring Inc 从事临床阶段的生物制药活动，重点是开发癌症疗法。该公司还专注于包括免疫肿瘤药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250425091851a46617dd&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250425091851a46617dd&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","BYSI"],"gpt_icon":0},{"id":"2528899277","title":"万春医药上涨3.31%，报1.25美元/股，总市值5039.54万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2528899277","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2528899277?lang=zh_cn&edition=full","pubTime":"2025-04-17 03:37","pubTimestamp":1744832226,"startTime":"0","endTime":"0","summary":"4月17日，万春医药盘中上涨3.31%，截至03:37，报1.25美元/股，成交1.73万美元，总市值5039.54万美元。财务数据显示，截至2024年06月30日，万春医药收入总额100.0万美元，同比增长14.29%；归母净利润-726.2万美元，同比增长42.91%。大事提醒：5月5日，万春医药将披露2024财年年报。资料显示，万春药业公司是一家处于全球临床阶段的生物制药公司,专注于新型癌症疗法,包括晚期肿瘤免疫药物的研发。公司成立于2013年,总部设立在美国。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250417034648973a43c1&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250417034648973a43c1&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","BYSI"],"gpt_icon":0},{"id":"2527419334","title":"万春医药盘中异动 早盘股价大涨8.55%报1.27美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2527419334","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2527419334?lang=zh_cn&edition=full","pubTime":"2025-04-15 23:22","pubTimestamp":1744730564,"startTime":"0","endTime":"0","summary":"北京时间2025年04月15日23时22分，万春医药股票出现异动，股价急速上涨8.55%。截至发稿，该股报1.27美元/股，成交量2127股，换手率0.01%，振幅9.40%。机构评级方面，目前暂无机构对该股做出“买入、持有、卖出”建议。万春医药股票所在的生物技术行业中，整体跌幅为0.09%。万春医药公司简介：BeyondSpring Inc 从事临床阶段的生物制药活动，重点是开发癌症疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250415232244aa2c7016&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250415232244aa2c7016&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BYSI","BK4139"],"gpt_icon":0},{"id":"2527153261","title":"万春医药上涨4.55%，报1.15美元/股，总市值4636.38万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2527153261","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2527153261?lang=zh_cn&edition=full","pubTime":"2025-04-15 00:38","pubTimestamp":1744648687,"startTime":"0","endTime":"0","summary":"4月15日，万春医药盘中上涨4.55%，截至00:38，报1.15美元/股，成交3647.0美元，总市值4636.38万美元。财务数据显示，截至2024年06月30日，万春医药收入总额100.0万美元，同比增长14.29%；归母净利润-726.2万美元，同比增长42.91%。大事提醒：5月5日，万春医药将披露2024财年年报。资料显示，万春药业公司是一家处于全球临床阶段的生物制药公司,专注于新型癌症疗法,包括晚期肿瘤免疫药物的研发。公司成立于2013年,总部设立在美国。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202504150045489737a14f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202504150045489737a14f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","BYSI"],"gpt_icon":0},{"id":"2526615218","title":"万春医药盘中异动 下午盘快速跳水5.50%报1.03美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2526615218","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2526615218?lang=zh_cn&edition=full","pubTime":"2025-04-12 01:14","pubTimestamp":1744391676,"startTime":"0","endTime":"0","summary":"北京时间2025年04月12日01时14分，万春医药股票出现波动，股价快速跳水5.50%。截至发稿，该股报1.03美元/股，成交量3035股，换手率0.01%，振幅4.15%。机构评级方面，目前暂无机构对该股做出“买入、持有、卖出”建议。万春医药股票所在的生物技术行业中，整体涨幅为1.34%。万春医药公司简介：BeyondSpring Inc 从事临床阶段的生物制药活动，重点是开发癌症疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250412011436a45662eb&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250412011436a45662eb&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","BYSI"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.beyondspringpharma.com","stockEarnings":[{"period":"1week","weight":-0.0562},{"period":"1month","weight":0.3884},{"period":"3month","weight":-0.0176},{"period":"6month","weight":0.037},{"period":"1year","weight":-0.4064},{"period":"ytd","weight":0.0307}],"compareEarnings":[{"period":"1week","weight":0.045},{"period":"1month","weight":0.0983},{"period":"3month","weight":-0.0316},{"period":"6month","weight":0.008},{"period":"1year","weight":0.1145},{"period":"ytd","weight":0.0075}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"万春医药公司于2014年11月21日在开曼群岛注册成立。该公司是一家处于全球临床阶段的生物制药公司,专注于新型癌症疗法，包括晚期肿瘤免疫药物的研发。在万春医药，其使命是利用他们的癌症治疗的学术及业务能力，采用独有方式来改变癌症治疗的现状。公司成立于2013年，总部设立在美国。他们的主要项目普那布林来源于天然化合物，由于所具有的各种生化活性，对多种癌症有治疗潜力。他们采用一种新颖的、高度可扩展的商业模式，整合美中优势资源，高效、低成本地实现药物的报批和开发。","yearOnYearQuotes":[{"month":1,"riseRate":0.5,"avgChangeRate":0.024795},{"month":2,"riseRate":0.5,"avgChangeRate":-0.048758},{"month":3,"riseRate":0.25,"avgChangeRate":0.104723},{"month":4,"riseRate":0.444444,"avgChangeRate":-0.021214},{"month":5,"riseRate":0.555556,"avgChangeRate":0.082388},{"month":6,"riseRate":0.625,"avgChangeRate":0.085714},{"month":7,"riseRate":0,"avgChangeRate":-0.133877},{"month":8,"riseRate":0.5,"avgChangeRate":0.274217},{"month":9,"riseRate":0.5,"avgChangeRate":-0.076896},{"month":10,"riseRate":0.25,"avgChangeRate":-0.087605},{"month":11,"riseRate":0.25,"avgChangeRate":-0.067019},{"month":12,"riseRate":0.5,"avgChangeRate":0.187148}],"exchange":"NASDAQ","name":"万春药业","nameEN":"Beyondspring Inc"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.33.5","shortVersion":"4.33.5","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"万春药业(BYSI)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供万春药业(BYSI)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"万春药业,BYSI,万春药业股票,万春药业股票老虎,万春药业股票老虎国际,万春药业行情,万春药业股票行情,万春药业股价,万春药业股市,万春药业股票价格,万春药业股票交易,万春药业股票购买,万春药业股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"万春药业(BYSI)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供万春药业(BYSI)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}